Applied Optoelectronics Announces Equity Grants To Employees Under Inducement Plan
SUGAR LAND, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access […]
Concrete Pumping Holdings Sets First Quarter 2024 Earnings Conference Call for Thursday, March 7, 2024
DENVER, Feb. 22, 2024 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (“CPH” or the “Company”), a leading provider […]
Matthews International’s Engineering Business Establishes Hydrogen Fuel Cell (HFC) Development Center in Burlington, NC
PITTSBURGH, Feb. 22, 2024 (GLOBE NEWSWIRE) — Matthews International Corporation (NASDAQ GSM: MATW) (“Matthews”), a global provider of industrial technologies […]
FTAI Aviation Ltd. Reports Fourth Quarter and Full Year 2023 Results, Declares Dividend of $0.30 per Ordinary Share
NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) — FTAI Aviation Ltd. (NASDAQ: FTAI) (the “Company” or “FTAI”) today reported financial […]
eXp World Holdings Reports Q4 and Full-Year 2023 Results
BELLINGHAM, Wash., Feb. 22, 2024 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: EXPI), or the “Company”, the holding company […]
Applied Optoelectronics Reports Fourth Quarter and Full Year 2023 Results
SUGAR LAND, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access […]
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
– Generated Record Quarterly and Full-Year Net Revenue of $149.7 Million and $566.8 Million – – Achieved Quarterly and Full-Year […]
Hub Group, Inc. Declares Quarterly Dividend
OAK BROOK, Ill., Feb. 22, 2024 (GLOBE NEWSWIRE) — Hub Group, Inc. (Nasdaq: HUBG) today announced its Board of Directors […]
MercadoLibre, Inc. Reports Fourth Quarter 2023 Financial Results
Montevideo, Feb. 22, 2024 (GLOBE NEWSWIRE) — MercadoLibre, Inc. Reports Fourth Quarter 2023 Financial Results MONTEVIDEO, Uruguay; February 22, 2024; […]
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
Completed enrollment in initial RLY-2608 600mg + fulvestrant dose expansion cohort & initiated additional dose expansion cohorts with RLY-2608 400mg […]
